Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Yunwei Lu, Ziyan Xiao, Xiujuan Zhao, Yingjiang Ye, Shu Li, Fuzheng Guo, Haiyan Xue & Fengxue Zhu. (2024) Incidence, risk factors, and outcomes of the transition of HIPEC-induced acute kidney injury to acute kidney disease: a retrospective study. Renal Failure 46:1.
Read now
Read now
Chih-Chung Cheng, Hung-Chieh Yeh, Pei-Wen Su, Chien-Lin Ho & Sheng-Chi Chang. (2024) Risk factors of chronic kidney disease in cisplatin-based hyperthermia intraperitoneal chemotherapy. International Journal of Hyperthermia 41:1.
Read now
Read now
Chao-Yu Chen, Hung-Yu Chang, Chang-Hsien Lu, Min-Chi Chen, Tzu-Hao Huang, Li-Wen Lee, Yu-San Liao, Vincent Chin-Hung Chen, Wen-Shih Huang, Yu-Che Ou, Feng-Chi Lung & Ting-Yao Wang. (2020) Risk factors of acute renal impairment after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. International Journal of Hyperthermia 37:1, pages 1279-1286.
Read now
Read now
N. Laplace, V. Kepenekian, A. Friggeri, O. Vassal, F. Ranchon, C. Rioufol, W. Gertych, L. Villeneuve, O. Glehen & N. Bakrin. (2020) Sodium thiosulfate protects from renal impairement following hyperthermic intraperitoneal chemotherapy (HIPEC) with Cisplatin. International Journal of Hyperthermia 37:1, pages 897-902.
Read now
Read now
Juan P. Cata, Acsa M. Zavala, Antoinette Van Meter, Uduak U. Williams, Jose Soliz, Mike Hernandez & Pascal Owusu-Agyemang. (2018) Identification of risk factors associated with postoperative acute kidney injury after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a retrospective study. International Journal of Hyperthermia 34:5, pages 538-544.
Read now
Read now
Grace Hwei Ching Tan, Nicholas Brian Shannon, Claramae Shulyn Chia, Khee Chee Soo & Melissa Ching Ching Teo. (2018) Platinum agents and mitomycin C-specific complications in cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). International Journal of Hyperthermia 34:5, pages 595-600.
Read now
Read now
Ji Su Kim, Ji Yeon Son, Kyeong Seok Kim, Hyun Jung Lim, Mee-Young Ahn, Seung Jun Kwack, Young-Mi Kim, Kwang Youl Lee, Jaewon Lee, Byung Mu Lee & Hyung Sik Kim. (2018) Hepatic damage exacerbates cisplatin-induced acute kidney injury in Sprague-Dawley rats. Journal of Toxicology and Environmental Health, Part A 81:11, pages 397-407.
Read now
Read now
Articles from other publishers (30)
Elea Vachez, Amaniel Kefleyesus, Naoual Bakrin, Florence Ranchon, Catherine Rioufol, Olivia Vassal, Omar Al-Hadeedi, Vahan Kepenekian & Olivier Glehen. (2024) Eliminating the need for preoperative intravenous hyperhydration: Sodium thiosulfate as nephrotoxicity prevention in HIPEC-treated patients – A retrospective analysis. European Journal of Surgical Oncology 50:2, pages 107955.
Crossref
Crossref
Zhi-yao You, Miao-fang Wu, Hui Li, Yan-fang Ye, Li-juan Wang, Zhong-qiu Lin & Jing Li. (2024) A phase I dose-finding trial of hyperthermic intraperitoneal docetaxel combined with cisplatin in patients with advanced-stage ovarian cancer. Journal of Gynecologic Oncology 35:1.
Crossref
Crossref
Claudèle Brault, Alexandre Brind’Amour, Lara de Guerke, Marie-Hélène Auclair, Lucas Sideris, Pierre Dubé, Mikaël Soucisse, Jean-François Tremblay, Laurence Bernard, Sabrina Piedimonte & Suzanne Fortin. (2023) Combined Interval Cytoreductive Surgery and Carboplatin-Based Hyperthermic Intraperitoneal Chemotherapy in Advanced Primary High-Grade Serous Ovarian Cancer. Current Oncology 30:12, pages 10272-10282.
Crossref
Crossref
Joannie Neveu, Elizabeth Tremblay, Frederic Mercier, Sébastien Garneau & Beatrice Cormier. (2023) Developing a hyperthermic intraperitoneal chemotherapy (HIPEC) gynecologic oncology program: a Canadian experience. International Journal of Gynecologic Cancer 33:12, pages 1957-1965.
Crossref
Crossref
Beatriz Navarro Santana, Esmeralda Garcia-Torralba, David Viveros-Carreño, Juliana Rodriguez, Rene Pareja, Alicia Martin, Sara Forte, Kate J Krause, J M González-Martín & Pedro T Ramirez. (2023) Complications of HIPEC for ovarian cancer surgery: evaluation over two time periods. International Journal of Gynecologic Cancer, pages ijgc-2023-004658.
Crossref
Crossref
Lukas F. Liesenfeld & Andreas Brandl. (2023) Influence of hyperthermic intraperitoneal chemotherapy on renal blood perfusion. Langenbeck's Archives of Surgery 408:1.
Crossref
Crossref
Lukas F. Liesenfeld, Eva Quiring, Mohammed Al-Saeedi, Christian Nusshag, Markus W. Büchler & Martin Schneider. (2022) Extensive Peritonectomy is an Independent Risk Factor for Cisplatin HIPEC-Induced Acute Kidney Injury. Annals of Surgical Oncology 30:5, pages 2646-2656.
Crossref
Crossref
Pengwei Chen, Jianhong Zhu, Yanchun Xu, Qiuyan Huang, Jianan Su, Ziqing Gao & Min Feng. (2023) Risk factors of immune checkpoint inhibitor-associated acute kidney injury: evidence from clinical studies and FDA pharmacovigilance database. BMC Nephrology 24:1.
Crossref
Crossref
Andrei Nikiforchin, Armando Sardi, Mary Caitlin King, Ekaterina Baron, Felipe Lopez-Ramirez, Carol Nieroda & Vadim Gushchin. (2022) Safety of Nephrectomy Performed During CRS/HIPEC: A Propensity Score-Matched Study. Annals of Surgical Oncology 30:4, pages 2520-2528.
Crossref
Crossref
Carlo Ronsini, Francesca Pasanisi, Pierfrancesco Greco, Luigi Cobellis, Pasquale De Franciscis & Stefano Cianci. (2023) Mininvasive Cytoreduction Surgery plus HIPEC for Epithelial Ovarian Cancer: A Systematic Review. Medicina 59:3, pages 421.
Crossref
Crossref
Yun Bai, Ye Du, Pengpeng Ye & Yang Luo. (2023) Acute kidney injury after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer. Frontiers in Oncology 13.
Crossref
Crossref
Liu-ping Zhang, Xiang Yang, Wei Zheng, Kai-xun Feng & Hu Li. (2023) Exploration of chemotherapy-free regimen after multi-line chemotherapy-induced renal impairment in recurrent ovarian cancer: Case report and literature review. Frontiers in Oncology 12.
Crossref
Crossref
Ebbe Billmann Thorgersen, Jørund Asvall, Camilla Schjalm, Karin Ekholt McAdam, Øyvind Sverre Bruland, Stein Gunnar Larsen & Tom Eirik Mollnes. (2023)
Effect of Intraperitoneal
224
Radium-Labelled Microparticles on Compartmentalized Inflammation After Cytoreductive Surgery and Hypertherm Intraperitoneal Chemotherapy
. Technology in Cancer Research & Treatment 22.
Crossref
Crossref
D. D. Morikov, V. I. Gorbachev, A. G. Pavlov, V. V. Dvornichenko, A. V. Shelekhov, N. D. Morikov & S. I. Radostev. (2022) Some Aspects of Postoperative Management of Patients with Ovarian Cancer after Cytoreductive Surgery Using Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Messenger of ANESTHESIOLOGY AND RESUSCITATION 19:2, pages 40-47.
Crossref
Crossref
Yumi Mitani, Yohei Arai, Tomohiro Mitani, Yoshimasa Gohda, Hideaki Yano, Isao Kondo, Emi Sakamoto, Daisuke Katagiri & Fumihiko Hinoshita. (2022) Association of intraoperative gross hematuria with acute kidney injury after cytoreductive surgery. Pleura and Peritoneum 7:1, pages 19-26.
Crossref
Crossref
Waleed Zafar, Kartik Kalra & David I. Ortiz-Melo. (2022) Oncosurgery-Related Acute Kidney Injury. Advances in Chronic Kidney Disease 29:2, pages 161-170.e1.
Crossref
Crossref
George Koritsiadis, Ilias Giannakodimos, Seferlis Miltiadis, Michalis Nomikos, George Athanasopoulos, Sarantis Papanikolaou & Thodoris Kouranos. (2022) The role of urologist in ovarian cancer debulking surgery. Hellenic Urology 34:2, pages 51.
Crossref
Crossref
Annika Kurreck, Felix Gronau, Miguel Enrique Alberto Vilchez, Wiltrud Abels, Philipp Enghard, Andreas Brandl, Roland Francis, Bettina Föhre, Christian Lojewski, Johann Pratschke, Peter Thuss-Patience, Dominik Modest, Beate Rau & Linda Feldbrügge. (2021) Sodium Thiosulfate Reduces Acute Kidney Injury in Patients Undergoing Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy with Cisplatin: A Single-Center Observational Study. Annals of Surgical Oncology 29:1, pages 152-162.
Crossref
Crossref
Lukas F. Liesenfeld, Benedikt Wagner, H. Christian Hillebrecht, Maik Brune, Christoph Eckert, Johannes Klose, Thomas Schmidt, Markus W. Büchler & Martin Schneider. (2021) HIPEC-Induced Acute Kidney Injury: A Retrospective Clinical Study and Preclinical Model. Annals of Surgical Oncology 29:1, pages 139-151.
Crossref
Crossref
Wu-yun Wang, Miao-fang Wu, Dong-bing Wu, Li-juan Wang, Hui Li, Zhong-qiu Lin & Jing Li. (2021) Calculating the dose of cisplatin that is actually utilized in hyperthermic intraperitoneal chemotherapy among ovarian cancer patients. Journal of Ovarian Research 14:1.
Crossref
Crossref
Álvaro Jesús Gómez-Ruiz, Alida González-Gil, José Gil, Felipe Alconchel, Álvaro Navarro-Barrios, Elena Gil-Gómez, Jerónimo Martínez, Aníbal Nieto, Carlos García-Palenciano & Pedro Antonio Cascales-Campos. (2021) Acute renal disease in patients with ovarian peritoneal carcinomatosis treated with cytoreduction and HIPEC: the influence of surgery and the cytostatic agent used. Langenbeck's Archives of Surgery 406:7, pages 2449-2456.
Crossref
Crossref
Bradley White, Fadi Dahdaleh, Samer A. Naffouje, Neerav Kothari, Jessica Berg, Wendy Wiemann & George I. Salti. (2021) Impact of Enhanced Recovery After Surgery on Postoperative Outcomes for Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Annals of Surgical Oncology 28:9, pages 5265-5272.
Crossref
Crossref
Kate Glennon, Karen Mulligan, Kirsten Carpenter, Ruth Mooney, Jurgen Mulsow, Orla McCormack, William Boyd, Tom Walsh, Ruaidhri McVey, Claire Thompson, Brid Ryan, Katie Padfield, Patrick Murray & Donal J Brennan. (2021) The addition of sodium thiosulphate to hyperthermic intraperitoneal chemotherapy with cisplatin in ovarian cancer. Gynecologic Oncology Reports 37, pages 100796.
Crossref
Crossref
Chui-ying Chan, Hui Li, Miao-fang Wu, Chang-hao Liu, Huai-wu Lu, Zhong-qiu Lin & Jing Li. (2021) A Dose-Finding Trial for Hyperthermic Intraperitoneal Cisplatin in Gynecological Cancer Patients Receiving Hyperthermic Intraperitoneal Chemotherapy. Frontiers in Oncology 11.
Crossref
Crossref
Matilde Zaballos, Mercedes Power, María Iluminada Canal-Alonso, María Ángeles González-Nicolás, Wenceslao Vasquez-Jimenez, Pablo Lozano-Lominchar, Pilar Cabrerizo-Torrente, Natividad Palencia-García, Susana Gago-Quiroga, María Dolores Ginel-Feito, Consuelo Jiménez, Alberto Lázaro & Luis González-Bayón. (2021) Effect of Cilastatin on Cisplatin-Induced Nephrotoxicity in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy. International Journal of Molecular Sciences 22:3, pages 1239.
Crossref
Crossref
Junwen Huang, Damin Xu & Li Yang. (2020) Acute Kidney Injury in Asia: Disease Burden. Seminars in Nephrology 40:5, pages 443-455.
Crossref
Crossref
Thanh H. Dellinger & Ernest S. Han. 2020. Cancer Regional Therapy. Cancer Regional Therapy
125
140
.
D. D. Morikov, A. V. Shelekhov, V. I. Gorbachev, V. V. Dvornichenko, A. G. Pavlov, S. I. Radostev, I. I. Osadchiy & T. G. Zyabreva. (2019) Anesthesiological support of cytoreducative operations using hyperthermic intraperitoneal chemotherapy (hipec) in patients with ovaryan cancer. Messenger of ANESTHESIOLOGY AND RESUSCITATION 16:5, pages 24-30.
Crossref
Crossref
Martina Aida Angeles, François Quenet, Pierre Vieille, Laurence Gladieff, Jean Ruiz, Muriel Picard, Federico Migliorelli, Leonor Chaltiel, Carlos Martínez-Gómez, Alejandra Martinez & Gwénaël Ferron. (2019) Predictive risk factors of acute kidney injury after cytoreductive surgery and cisplatin-based hyperthermic intra-peritoneal chemotherapy for ovarian peritoneal carcinomatosis. International Journal of Gynecologic Cancer 29:2, pages 382-391.
Crossref
Crossref
Samer A. Naffouje, Kiara A. Tulla, Regina Chorley, Nancy Armstrong & George I. Salti. (2018) Acute kidney injury increases the rate of major morbidities in cytoreductive surgery and HIPEC. Annals of Medicine and Surgery 35, pages 163-168.
Crossref
Crossref